The explanation for “Level of Research Activity” on the
Carnegie webpage states: “Doctoral universities were assigned to one of three
categories based on a measure of research activity. The research activity scale
includes the following correlates of research activity: research &
development (R&D) expenditures in science and engineering; R&D expenditures
in non-S&E fields; S&E research staff (postdoctoral appointees and
other non-faculty research staff with doctorates); doctoral conferrals in
humanities fields, in social science fields, in STEM (science, technology,
engineering, and mathematics) fields, and in other fields (e.g., business,
education, public policy, social work).”
An amendment to SB 8-A “Medical Use of Marijuana,” now Chapter
No. 2017-232, by state Sen. Darryl Rouson is expected to bring millions of new
research dollars to FAMU. The law instructs the Florida Department of Health to
“issue medical marijuana use registry identification cards for qualified
patients and caregivers who are residents of this state, which must be renewed
annually.”
A new law on “Industrial Hemp Pilot Projects,” originally
introduced as bill by state Sen. Bill Montford, also authorizes Florida A&M
University and the University of Florida “to cultivate, process, test,
research, create, and market safe and effective commercial applications for
industrial hemp in the agricultural sector in this state.”
A number of potential investors have already contacted FAMU
to express interest in partnering on industrial hemp opportunities. FAMU has
reestablished its Research Foundation to prepare to for this work.
The two laws provide new ways for FAMU to boost its R&D
expenditures, which could contribute to an eventual R1 classification.